FORWARD PHARMA A/S: Financial statements 2015
CVR: 28865880
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
FORWARD PHARMA A/S (CVR 28865880) has filed annual accounts for 2015. In 2015, the company reported a net result of USD -51,065,000 compared with USD -13,662,000 the year before. Equity in the 2015 report amounted to USD 176,695,000. The solvency ratio was 98.2%.
- Profit/Loss
- USD -51,065,000
- Equity
- USD 176,695,000
- Total Assets
- USD 179,933,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | - | -51.1 mio. USD | 176.7 mio. USD | - |
| 2014 | - | - | -13.7 mio. USD | 238 mio. USD | - |
| 2012 | - | -11 mio. | 22.4 mio. | 50.4 mio. | - |
Official annual report
How creditworthy is FORWARD PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of July 20, 2015, Jakob Mosegaard Larsen has joined the board of directors of FORWARD PHARMA A/S.
As of July 20, 2015, Grant Hellier Lawrence has joined the board of directors of FORWARD PHARMA A/S.
FORWARD PHARMA A/S has published its annual report for 2014. The net result was DKK -13,662,000.
About FORWARD PHARMA A/S
FORWARD PHARMA A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2005. The company has been dissolved on 26 November 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees (2018). In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity in the 2024 report amounted to DKK 488,330,233.